Combination composition, comprising as active ingredient L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

Details for Australian Patent Application No. 2011212153 (hide)

Owner SIGMA-TAU INDUSTRIE FARMACEUTICHE

Inventors Virmani, Mohamed Ashraf; Koverech, Aleardo

Agent Marks & Clerk Australia

Pub. Number AU-A-2011212153

PCT Pub. Number WO2011/095882

Priority 61/322,532 09.04.10 US; 10152363.7 02.02.10 EP

Filing date 7 February 2011

Wipo publication date 11 August 2011

International Classifications

A61K 31/205

A61K 31/7048

A61P 9/14 Drugs for disorders of the cardiovascular system

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/095882 Priority application(s): WO2011/095882

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212165-Identification, assessment, and therapy of cancers with innate or acquired resistance to ALK inhibitors

2011212150-Two-stage engine exhaust system